🏛️ Verified NIH Record • Updated 2026-08-10
A Study of Barzolvolimab in Patients With Atopic Dermatitis (NCT06727552)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab in Patients With Moderate to Severe Atopic Dermatitis
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic Sponsor: Celldex Therapeutics
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with Atopic Dermatitis
Who can join: Review the eligibility criteria below.
Location: Cahaba Dermatology & Skin Health Center, LLC — Birmingham, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (33 Sites)
Showing the first 25 of 33 sites.
- Cahaba Dermatology & Skin Health Center, LLC — Birmingham, Alabama
- Ohara Aivaz MD Dermatology — Beverly Hills, California
- Advanced Dermatology Center - Burbank — Burbank, California
- 310 Clinical Research — Inglewood, California
- Avance Trials — Laguna Niguel, California
- LA Universal Research Center, Inc. — Los Angeles, California
- UCLA Division of Dermatology — Los Angeles, California
- Dynasty Dermatology — Pasadena, California
- Acclaim Clinical Research — San Diego, California
- FOMAT Medical Research - Allergy, Asthma, & Immunology Medical Group — Ventura, California
- Focus Clinical Research — West Hills, California
- Direct Helpers Research Center — Hialeah, Florida
- International Dermatology Research Inc - Miami — Miami Lakes, Florida
- Sarasota Clinical Research — Sarasota, Florida
- Well Pharma Medical Research Corporation — South Miami, Florida
- Centricity Research Columbus Dermatology — Columbus, Georgia
- Georgia Skin and Cancer Clinic — Savannah, Georgia
- Treasure Valley Medical Research — Boise, Idaho
- Center for Medical Dermatology + Immunology Research — Chicago, Illinois
- Sneeze Wheeze and Itch Associates LLC — Normal, Illinois
- Equity Medical LLC — Bowling Green, Kentucky
- Allergy and Asthma Specialists PSC — Owensboro, Kentucky
- Onyx Clinical Research - Michigan — Flint, Michigan
- Revival Research Institute, LLC — Troy, Michigan
- Excel Clinical Research — Las Vegas, Nevada
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Atopic Dermatitis
- A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden — Birmingham, Alabama
- ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis — Phoenix, Arizona
- Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis — Chicago, Illinois
- A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis — Birmingham, Alabama
- A Study Evaluating APG777 in Atopic Dermatitis — Fountain Valley, California
Explore by condition: All Atopic Dermatitis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.